The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of high-dose whole pelvic simultaneous integrated boost IMRT in patients with pelvic lymph node-positive prostate cancer.
 
Takashi Mizowaki
Honoraria - AstraZeneca Japan; Bayer; Chugai Pharma; Daiichi Sankyo; Eisai; Elekta; Janssen; Takeda; Varian Medical Systems
Speakers' Bureau - Brainlab; Hitachi Chemical; Varian Medical Systems
Research Funding - Eisai; Mitsubishi Heavy Industries
 
Kenji Takayama
No Relationships to Disclose
 
Kiyonao Nakamura
Speakers' Bureau - Hitachi Chemical
 
Rihito Aizawa
Travel, Accommodations, Expenses - Janssen
 
Takahiro Inoue
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb Japan; Janssen; MSD Oncology; Ono Pharmaceutical; Sanofi/Aventis
Research Funding - Astellas Pharma
 
Toshinari Yamasaki
Speakers' Bureau - Novartis; Pfizer
 
Takashi Kobayashi
Honoraria - AstraZeneca Japan (I); Janssen
Consulting or Advisory Role - Janssen
 
Shusuke Akamatsu
Stock and Other Ownership Interests - Ono Pharmaceutical
Honoraria - Astellas Pharma; AstraZeneca Japan; Janssen
Research Funding - Astellas Pharma; AstraZeneca Japan
 
Osamu Ogawa
Honoraria - Astellas Pharma; AstraZeneca Japan; Janssen; Takeda